Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025)
Siga Technologies' (SIGA) quarterly Current Deferred Revenue came in at $10.2 million in Q4 2025, down 0.88% on a YoY basis from $10.3 million in Q4 2024, and little changed quarter-over-quarter from $10.2 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Current Deferred Revenue for 10 consecutive years, with $10.2 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue fell 0.88% year-over-year to $10.2 million; the trailing twelve-month figure through Dec 2025 stood at $10.2 million (down 0.88% YoY), and the FY2025 full-year result was $10.2 million, down 0.88% from the prior year.
- Current Deferred Revenue was little changed at $10.2 million in Q4 2025 per SIGA's latest filing, from $10.2 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $21.9 million in Q3 2023 and bottomed at $793464.0 in Q1 2022.
- Historically, Current Deferred Revenue has averaged $10.7 million across 5 years, with a median of $10.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue tumbled 77.8% in 2022, then jumped 1226.02% in 2023.
- Over 5 years, Current Deferred Revenue stood at $3.8 million in 2021, then surged by 180.2% to $10.5 million in 2022, then jumped by 97.07% to $20.8 million in 2023, then tumbled by 50.31% to $10.3 million in 2024, then fell by 0.88% to $10.2 million in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $10.2 million, $10.2 million, and $10.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 10.24 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 10.33 Mn |
| Sep 30, 2024 | 13.73 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 20.79 Mn |
| Dec 31, 2023 | 20.79 Mn |
| Sep 30, 2023 | 21.90 Mn |
| Jun 30, 2023 | 11.37 Mn |
| Mar 31, 2023 | 10.52 Mn |
| Dec 31, 2022 | 10.55 Mn |
| Sep 30, 2022 | 10.13 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 793,464.00 |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 3.59 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 3.28 Mn |